NeRRe: Advancing Neurokinin Receptor Antagonists

Video interview
NeRRe Therapeutics' Mary Kerr speaks to Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business